Literature DB >> 15492819

Relationship between activation of epidermal growth factor receptor and cell dissociation in pancreatic cancer.

Xiaodong Tan1, Hiroshi Egami, Shinji Ishikawa, Masahide Nakagawa, Takatoshi Ishiko, Hidenobu Kamohara, Masahiko Hirota, Michio Ogawa.   

Abstract

In our previous investigations, mitogen-activated protein kinase kinase 2 (MEK2)/extracellular signal-regulated kinase 2 (ERK2) signaling pathway was found to be correlated with the cell dissociation induced by dissociation factor (DF) in pancreatic cancer cells. In this study, the expressions of epidermal growth factor receptor (EGFR), phosphorylated EGFR (p-EGFR), and its downstream kinases MEK1/2 and ERK1/2, were analyzed to clarify the regulatory mechanism of cell dissociation in pancreatic cancer cells. Two hamster (PC-1.0 and PC-1) and two human (AsPC-1 and Capan-2) pancreatic cancer cell lines were used. Immunocytochemical study was performed using anti-EGFR, p-EGFR, phosphorylated MEK1/2 (p-MEK1/2), and phosphorylated ERK1/2 (p-ERK1/2) antibodies. DF-treatment markedly induced the expressions of EGFR, p-EGFR, p-MEK1/2, p-ERK1/2, as well as the dissociation of cell colonies in PC-1 and Capan-2 cells. In contrast, AG1478 (an EGFR inhibitor) treatment significantly induced the cell aggregation in PC-1.0 and AsPC-1 cells which usually grew as single cells, but strongly suppressed the expressions of EGFR, p-EGFR, p-MEK1/2, and p-ERK1/2. These observations demonstrate that activation of EGFR is closely involved in cell dissociation in pancreatic cancer through activating MEK/ERK signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15492819

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  7 in total

Review 1.  Systematic review of peri-operative prognostic biomarkers in pancreatic ductal adenocarcinoma.

Authors:  Wilson Petrushnko; Justin S Gundara; Philip R De Reuver; Greg O'Grady; Jaswinder S Samra; Anubhav Mittal
Journal:  HPB (Oxford)       Date:  2016-07-14       Impact factor: 3.647

2.  Overexpression of cellular inhibitor of apoptosis protein 2 is an early event in the progression of pancreatic cancer.

Authors:  Irene Esposito; Jörg Kleeff; Ivane Abiatari; Xined Shi; Nathalia Giese; Frank Bergmann; Wilfried Roth; Helmut Friess; Peter Schirmacher
Journal:  J Clin Pathol       Date:  2006-06-14       Impact factor: 3.411

3.  Involvement of MMP-7 in invasion of pancreatic cancer cells through activation of the EGFR mediated MEK-ERK signal transduction pathway.

Authors:  X Tan; H Egami; M Abe; F Nozawa; M Hirota; M Ogawa
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

4.  Evaluation of phosphatidylinositol-3-kinase catalytic subunit (PIK3CA) and epidermal growth factor receptor (EGFR) gene mutations in pancreaticobiliary adenocarcinoma.

Authors:  Guy A Weiss; Michael R Rossi; Nikhil I Khushalani; Ken Lo; John F Gibbs; Anubha Bharthuar; John K Cowell; Renuka Iyer
Journal:  J Gastrointest Oncol       Date:  2013-03

5.  Differential expression profiles of microRNAs in highly and weakly invasive/metastatic pancreatic cancer cells.

Authors:  Xiaodong Tan; Lei Zhou; Huaitao Wang; Yifan Yang; Yang Sun; Zhaoping Wang; Xiaobo Zhang; Feng Gao; Hansi Li
Journal:  Oncol Lett       Date:  2018-08-23       Impact factor: 2.967

6.  Effects of an epidermal growth factor receptor-based cancer vaccine on wound healing and inflammation processes in murine experimental models.

Authors:  Dasha Fuentes; Lewis Chacón; Angel Casacó; Nuris Ledón; Nidia Fernández; Arianna Iglesias; Diana R Hernández; Belinda Sánchez; Rolando Pérez
Journal:  Int Wound J       Date:  2012-09-04       Impact factor: 3.315

7.  Phosphoproteome Analysis of Invasion and Metastasis-Related Factors in Pancreatic Cancer Cells.

Authors:  Xiaodong Tan; Peng Liu; Yinpeng Huang; Lei Zhou; Yifan Yang; Huaitao Wang; Boqiang Yu; Xiangli Meng; Xiaobo Zhang; Feng Gao
Journal:  PLoS One       Date:  2016-03-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.